Tianyi Wang

Tianyi Wang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2021 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
NFNing Fan
Ning Fan
YSYuan Shuo
Yuan Shuo
PDPeng Du
Peng Du
QWqichao wu
qichao wu
TWTianyi Wang
Tianyi Wang
LZLei Zang
Lei Zang
Background: With the advancements in surgical methods, optical designs, and surgical instruments, percutaneous endoscopic transforaminal discectomy (PETD) has become an effective and minimally invasive procedure to treat lumbar spinal stenosis (LSS) in recent years. Few studies have focused on the complications associated with the treatment of LSS using percutaneous endoscopic lumbar discectomy (PELD). This study aimed to summarize the complications of PETD and identify the associated risk factors. Methods: Complications in a total of 738 consecutive LSS patients who underwent single-level PETD were retrospectively recorded and analyzed between January 2016 and July 2020. In addition, a matched case-control study was designed, and according to the date of operation, the control group was matched with patients without complications, with a matching ratio of 1:3. Demographic parameters included age, sex, BMI, smoking and drinking status, comorbidity, and surgical level. The radiological parameters included grade of surgical-level disc degeneration, number of degenerative lumbar discs, grade of lumbar spinal stenosis, degenerative lumbar scoliosis, lumbar lordosis, disc angle, and disc height index. Univariate analysis was performed using independent samples t-test and chi-squared test. Results: The incidence of different types of complications was 9.76% (72/738). The complications and occurrence rates were as follows: recurrence of LSS (rLSS), 2.30% (17/738); persistent lumbosacral or lower extremity pain, 3.79% (28/738); dural tear, 1.90% (14/738); incomplete decompression, 0.81% (6/738); surgical site infection, 0.41% (3/738); epidural hematoma, 0.27% (2/738); and intraoperative posterior neck pain, 0.27% (2/738). Univariate analysis demonstrated that age, the grade of surgical-level disc degeneration (P < 0.001) and the number of disc degeneration levels (P = 0.004) were significantly related to the complications. Conclusion: Complications in the treatment of LSS using PELD included rLSS, persistent pain of the lumbosacral or lower extremity, dural tear, incomplete decompression, surgical site infection, epidural hematoma, and intraoperative posterior neck pain. In addition, old age, severe grade of surgical-level disc degeneration and more disc degeneration levels significantly increased the incidence of complications.





21 November 2025 in Medicine
Verified
Journal Article
Open access
PDPeng Du
Peng Du
TLTusheng Li
Tusheng Li
NFNing Fan
Ning Fan
BWBaodong Wang
Baodong Wang
TWTianyi Wang
Tianyi Wang
LZLei Zang
Lei Zang
Insulin-like growth factor binding proteins (IGFBPs) are important regulatory factors of bone metabolism. However, the association between IGFBPs and osteoporosis remains a subject of contention in observational studies. We conducted a 2-sample Mendelian randomization (MR) study to assess the causal relationship between IGFBP 1-7 and osteoporosis using publicly available genome-wide association study summary statistics. The IGFBP 1-7 datasets were derived from German cohort studies and were selected at the genome-wide significance level ( P  < 5 × 10 -6 ). The osteoporosis dataset was obtained from the UK Biobank study and included 484,598 individuals of European ancestry. Inverse variance weighting (IVW) was used as the primary MR method to investigate the causal relationship between exposure and outcome. To make the conclusions more robust and reliable, we used Cochran Q statistics, MR-Egger regression, and leave-one-out analysis as sensitivity analyses. Based on the IVW results, we identified a causal relationship between IGFBP-2 and osteoporosis, in which IGFBP-2 prevented the development of osteoporosis (IVW, P  = .006; odds ratio = 0.998; β = −0.0022; 95% confidence interval: 0.996–0.999). However, the study did not show a significant causal relationship between the remaining 6 IGFBPs and osteoporosis ( P  > .05). In addition, the sensitivity analyses confirmed the findings in our study were robust. This MR study suggests a potential protective role of IGFBP-2 against osteoporosis and that it may serve as a biomarker or therapeutic target, although further research is needed.